Raghava Reddy Kethiri is our CSO with 25+ years of experience at various leadership positions in Biotech, CRO and Universities. Before joining LAXAI, he was associated with Karlsruhe Institute of Technology (KIT), Technical University of Dresden (TUD), JADO Technologies, Dresden, Germany and Jubilant Biosys Limited.
He successfully delivered several leads, optimised leads and PCCs/DCs across Oncology, Pain, CNS, MD and Antibacterial therapeutics areas for global pharmaceutical companies. He co-invented two Clinical Candidates ASN-001 (NCT 02349139) for Metastatic Castration Resistant Prostrate Cancer and ASN-007 (NCT 03415126) for metastatic KRAS, NRAS and HRAS mutated solid tumors. He co-authored over 60 publications/patents (US/EU/Indian).